Valuation: Merck KGaA

Capitalization 52.46B 61.02B 49.14B 45.8B 84.6B 5,492B 92.02B 575B 222B 2,594B 229B 224B 9,484B P/E ratio 2025 *
18.3x
P/E ratio 2026 * 18.1x
Enterprise value 60.48B 70.35B 56.65B 52.81B 97.53B 6,332B 106B 663B 256B 2,990B 264B 258B 10,934B EV / Sales 2025 *
2.86x
EV / Sales 2026 * 2.73x
Free-Float
29.72%
Yield 2025 *
1.91%
Yield 2026 * 2.02%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.87%
1 week+2.66%
Current month+3.23%
1 month+9.16%
3 months+7.93%
6 months+3.32%
Current year-14.40%
More quotes
1 week 115.55
Extreme 115.55
121.65
1 month 109.05
Extreme 109.05
125.6
Current year 100.7
Extreme 100.7
154.65
1 year 100.7
Extreme 100.7
154.65
3 years 100.7
Extreme 100.7
202.8
5 years 100.7
Extreme 100.7
231.5
10 years 70.68
Extreme 70.68
231.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2021-04-30
Director of Finance/CFO 55 2023-06-30
Chief Tech/Sci/R&D Officer - 2021-06-30
Director TitleAgeSince
Director/Board Member - 2019-04-25
Director/Board Member 63 2012-04-30
Director/Board Member 76 2014-05-08
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.87%+2.66%-15.49%-31.63% 61.02B
-0.90%-4.24%+0.48%-17.92% 8.57B
+0.60%-11.30%+30.85%+9.68% 7.45B
-1.69%-4.15%+31.63%+85.60% 7.12B
-0.93%-3.85%+2.09%+118.82% 5.94B
+1.50%+4.52%+209.43%+67.16% 4.38B
+0.61%-3.01%-17.12%-4.85% 2.84B
+1.29%+0.20%+22.89%+28.28% 2.62B
-0.67%+1.50%+20.38%+48.33% 2.54B
+0.19%+0.39%-15.88%+4.77% 1.96B
Average -0.09%-1.49%+26.93%+30.82% 10.44B
Weighted average by Cap. -0.61%+1.08%+4.56%-1.99%
See all sector performances

Financials

2025 *2026 *
Net sales 21.13B 24.58B 19.8B 18.45B 34.08B 2,213B 37.07B 232B 89.41B 1,045B 92.27B 90.3B 3,821B 21.39B 24.88B 20.03B 18.67B 34.49B 2,239B 37.52B 234B 90.48B 1,058B 93.38B 91.39B 3,867B
Net income 2.84B 3.31B 2.66B 2.48B 4.58B 298B 4.99B 31.15B 12.03B 141B 12.41B 12.15B 514B 2.87B 3.34B 2.69B 2.5B 4.62B 300B 5.03B 31.42B 12.13B 142B 12.52B 12.25B 518B
Net Debt 8.02B 9.33B 7.51B 7B 12.94B 840B 14.07B 87.89B 33.94B 397B 35.02B 34.27B 1,450B 6B 6.98B 5.62B 5.24B 9.68B 628B 10.53B 65.77B 25.39B 297B 26.21B 25.65B 1,085B
More financial data * Estimated data
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.1%); - pharmaceutical products (40%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.9%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.7%), Switzerland (1.9%), Europe (22.6%), the United States (25.7%), North America (1.3%), China (13.5%), Asia/Pacific (19.6%), Latin America (7%), Middle East and Africa (3.7%).
Employees
62,346
More about the company
Date Price Change Volume
25-12-08 119.75 -0.91% 35,684
25-12-05 120.65 +1.05% 255,519
25-12-04 119.40 -0.42% 286,380
25-12-03 119.90 +2.70% 345,142
25-12-02 116.75 +0.09% 186,748

Delayed Quote Xetra, December 08, 2025 at 05:27 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
120.65EUR
Average target price
143.88EUR
Spread / Average Target
+19.25%
Consensus

Quarterly revenue - Rate of surprise